pharmaphorum May 25, 2023
Mike Smith

In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.

Separating the hype from the reality has always been a challenge when it comes to AI, and Prakash believes that many in the industry are giving the technology too much credit as a drug development game changer.

Jonah and Adityo break down how current AI systems work and discuss the inherent limitations of AI. And Adityo suggests some...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
Google goes all in with AI as it merges research teams
Is Mental Health ready for Generative AI?
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements
IoT, AI and the cloud: The holy trinity to green your digital ecosystem
Meta unveils Llama 3, claims it’s the ‘most capable’ open LLM

Share This Article